Dexco (DXCO3) reported on Wednesday, October 28, 2026, that it expects a negative impact of approximately R$ 190 million on its EBITDA (earnings before interest, taxes, depreciation and amortization) in the third quarter of 2026, due to non-recurring accounting write-offs related to the optimization of its industrial structure. The proposals were approved by the Board of Directors and will still be reviewed by the Audit Committee, Fiscal Council and external auditors.
According to the company, the accounting write-offs include R$ 172 million in the Metals and Sanitary Ware Division, mainly in property, plant and equipment and remaining inventories, R$ 8 million in the Ceramic Coatings Division due to the closure of the Urussanga (SC) plant, and R$ 10 million in other net non-recurring adjustments associated with the optimization of the portfolio and non-operating assets.
Dexco stressed that these adjustments will have no cash impact and are classified as non-recurring. The events will be detailed in the notes to the 3Q26 financial statements, which are scheduled to be released on November 4, 2026.
